Form D — Protego Biopharma, Inc.
0001231919-25-000568 · filed Dec 3, 2025
Offering
- Industry
- Other Health Care
- Exemptions
- 06b
- Total offering
- $130,442,180
- Total sold
- $32,942,190
- Minimum investment
- $0
- Investors
- —
- Sales commission
- —
- Finders' fees
- —
Issuer
- Name
- Protego Biopharma, Inc.
- CIK
- 1796909
- Entity
- Corporation
- Jurisdiction
- DELAWARE
- Year incorporated
- —
- Address
- 10945 VISTA SORRENTO PARKWAY, SUITE 150
SAN DIEGO, CA 92130 - Phone
- (858) 355-9290
Related persons
May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.
-
Brent J. Warner · Executive OfficerSAN DIEGO, CA Find on LinkedIn ↗
-
SHELLEY CHU · DirectorSAN DIEGO, CA Find on LinkedIn ↗
-
EDWARD HURWITZ · DirectorSAN DIEGO, CA Find on LinkedIn ↗
-
HELEN KIM · DirectorSAN DIEGO, CA Find on LinkedIn ↗
-
LAURA BRASS · DirectorSAN DIEGO, CA Find on LinkedIn ↗
-
TIM LOHOFF · DirectorSAN DIEGO, CA Find on LinkedIn ↗
-
JANWILLEM NAESENS · DirectorSAN DIEGO, CA Find on LinkedIn ↗
-
SAOUSSEN BEN HALIMA · DirectorSAN DIEGO, CA Find on LinkedIn ↗
-
JEFFERY KELLY · DirectorSAN DIEGO, CA Find on LinkedIn ↗
-
HANK MICHAEL PETRASSI · Executive OfficerSAN DIEGO, CA Find on LinkedIn ↗
View the original filing on SEC EDGAR ↗